Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - Dermira, Inc. | derm-10q_20170930.htm |
| EX-31.1 - EX-31.1 - Dermira, Inc. | derm-ex311_264.htm |
| EX-32.1 - EX-32.1 - Dermira, Inc. | derm-ex321_261.htm |
| EX-10.2 - EX-10.2 SUBLEASE - Dermira, Inc. | derm-ex102_269.htm |
| EX-31.2 - EX-31.2 - Dermira, Inc. | derm-ex312_263.htm |
| EX-10.1 - EX-10.1 LICENSE AGREEMENT - Dermira, Inc. | derm-ex101_270.htm |
Exhibit 32.2
CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Andrew L. Guggenhime, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:
(1) the Quarterly Report of Dermira, Inc. on Form 10-Q for the fiscal quarter ended September 30, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Dermira, Inc. for the periods presented therein.
|
Date: November 6, 2017 |
By: |
/s/ ANDREW L. GUGGENHIME |
|
|
|
Andrew L. Guggenhime |
|
|
|
Chief Operating Officer and Chief Financial Officer |
|
|
|
(Principal Financial Officer and Principal Accounting |
|
|
|
Officer) |